Clinical Trials
Moleculin Engages IQVIA to Manage Potential COVID-19 Clinical Trial
Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, announced the engagement of...
Clinical Trials
OSE Immunotherapeutics Receives Authorization for Phase 1 Clinical Trial...
OSE Immunotherapeutics announced that the Belgian Federal Agency for Medicines and Health Products (Agence Fédérale des Médicaments et des Produits de Santé - AFMPS) and...
Clinical Trials
Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine...
Pfizer Inc. and BioNTech SE announced that, in a Phase 3 trial in adolescents 12 to 15 years of age with or without prior evidence...
Clinical Trials
Daiichi Sankyo begins phase 1 trial in Japan for...
Daiichi Sankyo Company, Limited announced that it has initiated in Japan a first-in-human phase 1 trial for nafamostat inhalation formulation (DS-2319), which is being developed...
Clinical Trials
Humanigen Reports Positive Phase 3 Topline Results Improves Survival...
Humanigen, Inc., a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab, today announced...
Clinical Trials
Foresee Pharma Announces Dosing of First Patient in Phase...
Foresee Pharmaceuticals Co., Ltd. announced the initiation of patient dosing in the Phase 2/3 clinical trial of FP-025, its highly selective oral MMP-12 inhibitor, in...
Clinical Trials
Lilly, Vir And GSK Report Positive Topline Data From...
Eli Lilly and Company, Vir Biotechnology, Inc. and GlaxoSmithKline plc announced topline data from the expanded Phase 2 BLAZE-4 trial studying low-risk adult patients with...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.